Comparative Clinical and Economic Outcomes among Venous Thromboembolism Patients who Initiated Apixaban or Warfarin in the United States Medicare Population (VTE CER in Medicare) First published 19/07/2018 Last updated 02/06/2020 EU PAS number:EUPAS24902 Study Finalised